Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 430.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.19%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 430.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIB Q1 2018 Trading Statement

25 Apr 2018 07:00

RNS Number : 0041M
AIB Group PLC
25 April 2018
 

 

 

 

 

EMBARGO 07:00

25 April 2018

 

AIB Group pLC - Q1 2018 Trading update (UNAUDITED)

 

AIB releases the following update in advance of its AGM which takes place today at 11:00 (BST).

 

A good start to 2018 and performing to expectations

 

 "Q1 delivered a good start to the year with strong profitability, capital generation and continued loan book growth. The quality of the loan book also improved with increased new lending and further NPE reductions. In the quarter, we commenced our MREL issuance programme, executing a successful HoldCo transaction. We continue to focus on meeting our customers' needs, simplifying our operating model and increasing efficiency which positions us well for the remainder of the year."

- Bernard Byrne, CEO

 

Key Highlights

· Fully loaded CET1 17.1% driven by strong profitability offset by IFRS 9 impact and dividend accrual

· Holding normalised Net Interest Margin (NIM) of 2.50% for Q1, excluding cured loan interest

· Gross loans increased by €0.3bn to €63.6bn in the quarter; new lending up 18% in Ireland

· Disciplined cost management with stable costs year on year

· NPEs reduced by 10% to €9.2bn from €10.2bn in December 2017

 

Economic Environment

The positive momentum continues in the Irish economy. In 2017, economic growth as measured by Modified Final Domestic Demand (which excludes some multi-national activity) grew by 4%. The number in employment continues to rise by c. 3% per annum while the unemployment rate declined for a sixth consecutive month in February 2018, falling to a near 10-year low of 6.1%. Activity metrics in the housing market are positive although the pace of housing supply is still some way short of estimated demand.

 

As global macro-economic and geo-political risks rise, notwithstanding a continued buoyant economic backdrop, we are cognisant of uncertainties and potential challenges in the medium term. We continue to support our Irish and UK-based customers, working closely with them to better understand any potential implications, with particular reference to Brexit.

 

Financial Performance

The Group is performing well and remains on track to meet its medium term targets.

 

In Q1 2018 NIM was 2.53% and in line with the prior year equivalent period (Q1 2017: 2.53% incl ELG). Excluding income from cured loans, normalised NIM was 2.50%, consistent with FY 2017 NIM. This reflects lower funding costs offset by the disposal of high yielding government bonds and the absorption of Q4 mortgage pricing changes.

 

Fees and commission income remained stable in the quarter.

Group operating costs to 31 March 2018 were as anticipated and in line with Q1 last year. As previously stated, the factors expected to impact costs in 2018 include wage inflation, continued investment in loan restructuring and increased depreciation. We continue to invest to generate efficiencies and harvest benefits from the ongoing simplification of our operating model. We continue to focus on cost management and are confident of achieving our sustainable cost income ratio target of less than 50% by end 2019.

 

Regulatory costs and levies for 2018, relating to the Single Resolution Fund (SRF), the Deposit Guarantee Scheme (DGS) and the Bank Levy, are expected to be in line with full year 2017 (€105m).

 

A net credit provision write-back was recorded in Q1, however, we recognise the scope for some volatility in provisioning in the short term due to the introduction of IFRS 9 and the move to lifetime expected loss calculation.

 

We continue to make progress on the Tracker Mortgage Review. 96% of identified impacted customers have received payment and the remaining identified customers will be paid in Q2. The related provisions are unchanged.

 

Balance Sheet

The performing loan book increased from December 2017 to March 2018 as new lending exceeded redemptions. Gross loans of €63.6bn were up €0.3bn, however an equal increase in provisions due to IFRS 9 implementation resulted in a flat net loan book of €60.0bn.

 

New lending drawdowns in the quarter were strong. Lending in Ireland increased by 18% on the prior year period. Our market share(1) of mortgage drawdowns in the month of February was 33%, up on month December 2017, and a positive trend in applications continues. In the UK, new lending was lower in Q1 2018 compared to the prior year period, overall however, the UK loan book has remained stable since December.

 

Non-performing exposures (NPEs)(2) reduced by €1.0bn to €9.2bn driven by continued case by case resolution (c. €400m) and the impact of harmonisation of definitions of defaulted loans under IFRS 9(3).The normalisation of NPEs remains a key focus and a strategic priority for the Bank.

 

Customer accounts of €64.8bn increased from €64.6bn at December 2017 primarily as current accounts continue to grow. During Q1 2018, we sold a €0.5bn high yielding government bond within our AFS portfolio to lower this balance to €15.7bn at March 2018. The loan to deposit ratio was 93% at the end of Q1 2018.

 

Funding & Capital

In Q1 2018 we delivered a successful €500m 5 year HoldCo Senior transaction priced at mid-swaps +115bps. The quality and breadth of investor interest (4.2x oversubscribed) for our inaugural HoldCo transaction is a positive result as we commence our MREL issuance programme.

 

The fully loaded CET1 at the end of Q1 was 17.1% (Dec 2017: 17.5%) driven by strong profitability offset predominantly by IFRS 9 impact(3), a marginal increase in RWA and dividend accrual.

 

Outlook

We have had a good start to the year and remain on track to meet expectations. The economic backdrop is favourable and our customer first strategy is delivering results. We continue to make progress on our key priorities of delivering for our customers, driving efficiencies through the evolution of our operating model and reducing NPEs to normalised levels. With strong profitability and capital generation, we are well positioned to deliver for our customers and shareholders.

 

(1) Source: BPFI February 2018

(2) NPEs can broadly be split into two categories: customers that we have resolved subject to a probationary period or completion of property sales before the loans exit from NPE; customers yet to be resolved (previously defined as impaired and 90 days past due)

(3) Subject to finalisation

-ENDS-

 

 

For further information, please contact:

Mark Bourke

Niamh Hore

Orla Bird

Chief Financial Officer

Head of Equity Investor Relations

Head of Communications

AIB Bankcentre

AIB Bankcentre

AIB Bankcentre

Dublin

Dublin

Dublin

Tel: +353-1-6412195

Tel: +353-1-6411817

Tel: +353-1-6415375

email:

mark.g.bourke@aib.ie

 

email:

niamh.a.hore@aib.ie

email:

orla.c.bird@aib.ie

 

 

 

Forward Looking Statements

 

This announcement contains certain forward-looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'aim', 'anticipate', 'target', ' expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking information. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. These are set out in the 'Principal risks and uncertainties' on pages 58 to 68 of the Annual Financial Report 2017. In addition to matters relating to the Group's business, future performance will be impacted by Irish, UK and wider European and global economic and financial market considerations. Any forward-looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 58 to 68 of the Annual Financial Report 2017 is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward-looking statement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKQDNCBKDDQB
Date   Source Headline
9th May 20245:11 pmRNSHolding(s) in Company
9th May 20244:53 pmRNSHolding(s) in Company
8th May 202410:33 amRNSTotal Voting Rights
7th May 20245:36 pmRNSHolding(s) in Company
7th May 20247:00 amRNSHolding(s) in Company
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20246:01 pmRNSResult of Meeting
2nd May 20246:00 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Statement
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company
7th Nov 20237:08 amRNSAIB Group plc - Statement on State Divestment
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment
28th Jun 20237:00 amRNSResults of Secondary Placing in AIB Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.